Press release
Mumbai Hosts Powerful Premiere of The Protagonist Show and Launch of Sheroes Amongst Us
In a stirring evening of storytelling, empowerment, and emotion, The Protagonist Show premiered alongside the launch of the book Sheroes Amongst Us - Real Women Real Stories at an exclusive event on June 21. Held in Mumbai, the event was powered by Etherwire.ai, a Multiplaylist Platform, and F13 Happenings.Co-authored by Falguni Desai and Dr. Amit Nagpal, the book highlights real-life stories of women who transformed adversity into strength, inspiring audiences to recognize the hero within. These stories were brought to life through The Protagonist Show, an innovative family entertainer that merges literature with live-action narrative.
Jyoti Rai, Founder of Etherwire.ai and one of the featured Sheroes, shared, "We created a tribute that reimagines books as mainstream, heart-touching entertainment. It's a new way to honour authors and inspire families."
The evening resonated with students, professionals, and families. Emotional reflections poured in from speakers including Col. S.S. Chandhoke, Vaisshali Babu, and Ranjana Maitra, who praised the show's heartfelt message.
Filmmaker Shashie Verma, whose studio Sceneworks collaborated on the project, added, "This is just the beginning of telling a million untold stories."
Protagonists Dr. Shilpi Thapar, Rajani Tiwari, and Roma Balwani echoed the sentiment: "This wasn't just a celebration-it was a mirror, a movement, and a memory."
Mumbai
Insight Media is a forward-thinking media and communications company committed to creating impactful narratives across digital platforms. Established with a vision to bridge the gap between brands and their audiences, Insight Media specializes in content creation, public relations, and strategic communication services tailored to today's fast-paced digital landscape.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mumbai Hosts Powerful Premiere of The Protagonist Show and Launch of Sheroes Amongst Us here
News-ID: 4080068 • Views: …
More Releases for Protagonist
Polycythemia Vera Drugs Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom, and Japan.
Discover which therapies are expected to grab the Polycythemia Vera Market Share @ Polycythemia Vera Market Outlook- https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Polycythemia Vera Market Report
• In…
Polycythemia Vera Market to Show Remarkable Growth Trends from 2024 to 2034, Del …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Polycythemia Vera market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Polycythemia Vera Market Forecast
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Polycythemia Vera Market Predicted to See Upsurge Through 2034, Highlights Delve …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Polycythemia Vera market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Polycythemia Vera Market Forecast
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Polycythemia Vera Market to Observe Impressive Growth During the Forecast Period …
DelveInsight's "Polycythemia Vera Market Insights, Epidemiology, and Market Forecast-2032″ report offers an in-depth understanding of the Polycythemia Vera, historical and forecasted epidemiology as well as the Polycythemia Vera market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Polycythemia Vera market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Polycythemia Vera Market Forecast
https://www.delveinsight.com/sample-request/polycythemia-vera-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Hereditary Hemochromatosis (HH) Market to Witness Growth by 2032, Estimates Delv …
DelveInsight's "Hereditary Hemochromatosis (HH) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Hereditary Hemochromatosis (HH), historical and forecasted epidemiology as well as the Hereditary Hemochromatosis (HH) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Hereditary Hemochromatosis (HH) market report provides current treatment practices, emerging drugs, the market share of the individual therapies, and the current and forecasted…
Investigation announced for Investors in Protagonist Therapeutics, Inc. (NASDAQ: …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Protagonist Therapeutics, Inc.
Investors who purchased shares of Protagonist Therapeutics, Inc. (NASDAQ: PTGX) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain Protagonist Therapeutics directors breached their fiduciary duties and caused damage to the company and its shareholders.
Newark, CA based Protagonist…